Multiple Myeloma Research Foundation

From Wikipedia, the free encyclopedia
Jump to: navigation, search

The Multiple Myeloma Research Foundation (MMRF) is a charitable organization dedicated to multiple myeloma, an incurable blood cancerh year. The MMRF runs as if it were a for-profit business, expecting high returns from the money the organization raises from donors.[1]


MMRF was founded in 1998 by twin sisters Kathy Giusti and Karen Andrews, following Kathy's diagnosis with multiple myeloma. Giusti, a pharmaceutical company executive and Harvard Business School Alum, wanted to encourage researchers to develop treatments for multiple myeloma by using business models rather than academic models of drug development. [1]

About The MMRF[edit]

MMRF is the number-one private funder of multiple myeloma research, having raised over $120 million since its inception to fund more than 120 laboratories worldwide.[2] MMRF has developed a diverse research “portfolio” of programs to yield long-, mid-, and short-term returns on the MMRF’s research investment and deliver better treatments to patients faster: basic science programs to better understand the disease and identify new druggable targets through genomics and proteomics research; validation programs to prioritize new compounds and combinations based on key targets; and a network of leading myeloma centers who collaborate to conduct clinical trials to accelerate the development of novel treatments.[citation needed]

The MMRF is funding research into 30 compounds at the pre-clinical stage.[3] By 2013 it had raised more than $250 million and its work has resulted in approval of six new drugs to treat the disease.[4]

See also[edit]


  1. ^ a b Groopman, Jerome (January 28, 2008). "Buying a Cure.(Kathy Giusti's Multiple Myeloma Research Foundation)". The New Yorker. Retrieved 16 December 2009. 
  2. ^ "Harvard Business School Awards MMRF Founder, CEO with Alumni Achievement Award". Reuters (Business wire). 2009-10-22. Retrieved 16 December 2009. 
  3. ^ Duxbury, Sarah (December 8, 2006). "Foundations move in where VCs fear to tread". San Francisco Business Times. Retrieved 16 December 2009. 
  4. ^ "A Mission with Precision", Forbes Magazine, December 3, 2013

External links[edit]